Dimensional Fund Advisors LP Sells 49,780 Shares of Enhabit, Inc. (NYSE:EHAB)

Dimensional Fund Advisors LP lessened its position in shares of Enhabit, Inc. (NYSE:EHABFree Report) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,865,609 shares of the company’s stock after selling 49,780 shares during the period. Dimensional Fund Advisors LP owned about 3.72% of Enhabit worth $19,310,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Gladius Capital Management LP bought a new position in shares of Enhabit during the fourth quarter worth about $42,000. Quantbot Technologies LP acquired a new stake in shares of Enhabit in the third quarter valued at approximately $73,000. Louisiana State Employees Retirement System bought a new stake in shares of Enhabit in the fourth quarter worth $260,000. Brooks Moore & Associates Inc. grew its position in Enhabit by 5.1% in the third quarter. Brooks Moore & Associates Inc. now owns 26,950 shares of the company’s stock valued at $303,000 after purchasing an additional 1,300 shares in the last quarter. Finally, HighTower Advisors LLC acquired a new stake in Enhabit in the 3rd quarter valued at $310,000.

Enhabit Stock Performance

NYSE EHAB opened at $9.00 on Wednesday. The stock has a market cap of $451.35 million, a PE ratio of -5.42, a P/E/G ratio of 1.47 and a beta of 1.88. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.50 and a current ratio of 1.50. The firm has a 50-day moving average of $9.89 and a 200-day moving average of $10.08. Enhabit, Inc. has a 52-week low of $7.12 and a 52-week high of $14.59.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.02. Enhabit had a negative net margin of 7.95% and a positive return on equity of 1.43%. The firm had revenue of $262.40 million during the quarter, compared to the consensus estimate of $268.25 million. On average, sell-side analysts anticipate that Enhabit, Inc. will post 0.24 EPS for the current year.

Insider Activity at Enhabit

In other news, Director Jeffrey Bolton acquired 10,000 shares of the stock in a transaction on Friday, May 17th. The shares were purchased at an average price of $8.33 per share, for a total transaction of $83,300.00. Following the transaction, the director now directly owns 52,299 shares of the company’s stock, valued at $435,650.67. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders bought 22,000 shares of company stock worth $183,700 in the last ninety days. 1.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. UBS Group upgraded Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective for the company in a report on Thursday, March 7th. Leerink Partnrs raised Enhabit from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 14th. SVB Leerink raised Enhabit from an “underperform” rating to a “market perform” rating and set a $8.50 price objective for the company in a report on Tuesday, May 14th. Oppenheimer reaffirmed a “market perform” rating on shares of Enhabit in a research report on Thursday, March 7th. Finally, Jefferies Financial Group downgraded shares of Enhabit from a “buy” rating to a “hold” rating and cut their target price for the company from $14.00 to $8.75 in a research note on Thursday, May 9th. One investment analyst has rated the stock with a sell rating and seven have issued a hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.13.

Read Our Latest Stock Analysis on EHAB

Enhabit Company Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Stories

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.